Parental tdap boosters and infant pertussis: A case-control study

Copyright © 2014 by the American Academy of Pediatrics. BACKGROUND: Although recommended for almost a decade, evidence for field effectiveness of vaccinating close adult contacts of newborn infants against pertussis ("cocooning") is lacking. We evaluated the impact of a government-funded c...

Full description

Bibliographic Details
Main Authors: Quinn, H., Snelling, Thomas, Habig, A., Chiu, C., Spokes, P., McIntyre, P.
Format: Journal Article
Published: American Academy of Pediatrics 2014
Online Access:http://hdl.handle.net/20.500.11937/56228
_version_ 1848759819489509376
author Quinn, H.
Snelling, Thomas
Habig, A.
Chiu, C.
Spokes, P.
McIntyre, P.
author_facet Quinn, H.
Snelling, Thomas
Habig, A.
Chiu, C.
Spokes, P.
McIntyre, P.
author_sort Quinn, H.
building Curtin Institutional Repository
collection Online Access
description Copyright © 2014 by the American Academy of Pediatrics. BACKGROUND: Although recommended for almost a decade, evidence for field effectiveness of vaccinating close adult contacts of newborn infants against pertussis ("cocooning") is lacking. We evaluated the impact of a government-funded cocoon program during a pertussis epidemic in New South Wales, Australia. METHODS: We matched all New South Wales laboratory-confirmed pertussis cases aged < 4 months with onset between April 1, 2009, to March 30, 2011 to controls from the state birth register by date of birth and area of residence. Parental vaccine receipt was by self-report, with a subset verified. Parents were considered "immunized" if vaccinated =4 weeks before case symptom onset. The effectiveness of parental immunization (versus neither vaccinated) was quantified as (1 - odds ratio) × 100%. RESULTS: Case households had fewer immunized mothers (22% vs 32%) or fathers (20% vs 31%) but were more likely to include additional and older children. After adjustment, when both parents met our definition of immunized, risk of pertussis at < 4 months of age was reduced by 51% (95% confidence interval 10% to 73%). Maternal vaccination prepregnancy and an immunized father reduced the risk by 51% (95% confidence interval 0% to 76%). CONCLUSIONS: Timely parental pertussis boosters provided significant protection. Evidence of protection from maternal vaccination prepregnancy is biologically plausible, and more precise data on the magnitude and duration of this is important for future policy recommendations.
first_indexed 2025-11-14T10:05:57Z
format Journal Article
id curtin-20.500.11937-56228
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:05:57Z
publishDate 2014
publisher American Academy of Pediatrics
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-562282017-09-13T16:11:02Z Parental tdap boosters and infant pertussis: A case-control study Quinn, H. Snelling, Thomas Habig, A. Chiu, C. Spokes, P. McIntyre, P. Copyright © 2014 by the American Academy of Pediatrics. BACKGROUND: Although recommended for almost a decade, evidence for field effectiveness of vaccinating close adult contacts of newborn infants against pertussis ("cocooning") is lacking. We evaluated the impact of a government-funded cocoon program during a pertussis epidemic in New South Wales, Australia. METHODS: We matched all New South Wales laboratory-confirmed pertussis cases aged < 4 months with onset between April 1, 2009, to March 30, 2011 to controls from the state birth register by date of birth and area of residence. Parental vaccine receipt was by self-report, with a subset verified. Parents were considered "immunized" if vaccinated =4 weeks before case symptom onset. The effectiveness of parental immunization (versus neither vaccinated) was quantified as (1 - odds ratio) × 100%. RESULTS: Case households had fewer immunized mothers (22% vs 32%) or fathers (20% vs 31%) but were more likely to include additional and older children. After adjustment, when both parents met our definition of immunized, risk of pertussis at < 4 months of age was reduced by 51% (95% confidence interval 10% to 73%). Maternal vaccination prepregnancy and an immunized father reduced the risk by 51% (95% confidence interval 0% to 76%). CONCLUSIONS: Timely parental pertussis boosters provided significant protection. Evidence of protection from maternal vaccination prepregnancy is biologically plausible, and more precise data on the magnitude and duration of this is important for future policy recommendations. 2014 Journal Article http://hdl.handle.net/20.500.11937/56228 10.1542/peds.2014-1105 American Academy of Pediatrics unknown
spellingShingle Quinn, H.
Snelling, Thomas
Habig, A.
Chiu, C.
Spokes, P.
McIntyre, P.
Parental tdap boosters and infant pertussis: A case-control study
title Parental tdap boosters and infant pertussis: A case-control study
title_full Parental tdap boosters and infant pertussis: A case-control study
title_fullStr Parental tdap boosters and infant pertussis: A case-control study
title_full_unstemmed Parental tdap boosters and infant pertussis: A case-control study
title_short Parental tdap boosters and infant pertussis: A case-control study
title_sort parental tdap boosters and infant pertussis: a case-control study
url http://hdl.handle.net/20.500.11937/56228